
Alerts on Instil Bio TIL.O and ImmuneOnco Biopharmaceuticals 1541.HK announcing clinical trial updates for Phase 2 trial of ‘2510 were inadvertently tagged to T Rowe Price Large-Cap Value Fund TILCX.O, an unrelated company and have been withdrawn.
For the correct set of alerts, click nFWN3RU044
STORY_NUMBER: nFWN3RU0PH
STORY_DATE: 22/05/2025
STORY_TIME: 10:01:01 GMT